Phar­maron ex­pand­ing Liv­er­pool man­u­fac­tur­ing fa­cil­i­ty with a $186M+ price tag

Liv­er­pool may be known for rock and roll and pre­mier league foot­ball, but the Chi­na-based con­tract man­u­fac­tur­er Phar­maron is look­ing to make it a big­ger hub for cell and gene ther­a­py man­u­fac­tur­ing.

As part of Phar­maron’s fur­ther com­mit­ment to Mersey­side coun­ty, it plans to build an 8,000-square-me­ter fa­cil­i­ty, or around 86,000 square feet, which in­cludes a boost to the man­u­fac­tur­ing ca­pac­i­ty of 3,500 square me­ters, or 37,600 square feet. The price tag for the ex­pan­sion will be £151 mil­lion ($186 mil­lion), with Phar­maron re­ceiv­ing a grant from the UK Gov­ern­ment’s Life Sci­ences In­no­va­tion Man­u­fac­tur­ing Fund (LSIMF).

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN